These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15213426)

  • 1. 13C NMR chemical shifts of the triclinic and monoclinic crystal forms of valinomycin.
    Kameda T; McGeorge G; Orendt AM; Grant DM
    J Biomol NMR; 2004 Jul; 29(3):281-8. PubMed ID: 15213426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution solid-state 13C NMR study of free and metal-complexed macrocyclic antibiotic ionophores valinomycin, nonactin, and tetranactin: conformational elucidation in solid and solution by conformation-dependent 13C chemical shifts.
    Tabeta R; Saitô H
    Biochemistry; 1985 Dec; 24(26):7696-702. PubMed ID: 3841495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal and molecular structure of the centrosymmetric meso-valinomycin analogue--cyclo (D-Val-D-Hyi-D-Val-L-Hyi-L-Val-D-Hyi-L-Val-L-Hyi-L-Val-D-Hyi-D-Val-L-Hy i) (C60H102N6O18).
    Pletnev VZ; Fonarev YuD ; Tsygannik IN; Ivanov VT; Pletnev SV; Langs DA; Duax WL
    Biopolymers; 1995 Nov; 36(5):615-21. PubMed ID: 7578953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assignments of solid-state 13C resonances for polymorphs of cortisone acetate using shielding tensor components.
    Christopher EA; Harris RK; Fletton RA
    Solid State Nucl Magn Reson; 1992 Jun; 1(2):93-101. PubMed ID: 1365721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The X-ray structure of the monoclinic crystal form of [D-Hyi2, L-Hyi4] meso-valinomycin.
    Pletnev VZ; Ivanov VT; Langs DA; Burkhart BM; Duax WL
    Biopolymers; 1997 Nov; 42(6):645-50. PubMed ID: 9358730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both experimental and theoretical investigations of solid-state 17O NMR for L-valine and L-isoleucine.
    Yamada K; Nemoto T; Asanuma M; Honda H; Yamazaki T; Hirota H
    Solid State Nucl Magn Reson; 2006 Oct; 30(3-4):182-91. PubMed ID: 17074470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion-binding study by 17O solid-state NMR spectroscopy in the model peptide Gly-Gly-Gly at 19.6 T.
    Chekmenev EY; Waddell KW; Hu J; Gan Z; Wittebort RJ; Cross TA
    J Am Chem Soc; 2006 Aug; 128(30):9849-55. PubMed ID: 16866542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular conformation of a D,L stereoisomeric analogue of valinomycin, cyclo[-(L-Val-L-Hyi-L-Val-D-Hyi)2-(D-Val-L-Hyi-L-Val-D-Hyi)-].
    Langs DA; Grochulski P; Duax WL; Pletnev VZ; Ivanov VT
    Biopolymers; 1991 Mar; 31(4):417-23. PubMed ID: 1863693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Crystalline and molecular structure of the K+-complex of meso-valinomycin, cyclo(-(D-Val-L-Hyi-L-Val-D-Hyi)3-).KAuCl4].
    Pletnev VZ; Tsygannik IN; Fonarev IuD; Mikhaĭlova IIu; Kulikov IuV; Ivanov VT; Langs DA; Duax WL
    Bioorg Khim; 1995 Nov; 21(11):828-33. PubMed ID: 8670307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic Forms of Valinomycin Investigated by NMR Crystallography.
    Czernek J; Brus J
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of valinomycin-monohydrate cage complexes crystallized from dioxane.
    Langs DA; Blessing RH; Duax WL
    Int J Pept Protein Res; 1992 Apr; 39(4):291-9. PubMed ID: 1428520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Nuclear Magnetic Resonance Spectroscopy and Density Functional Theory Calculations to Characterize Carvedilol Polymorphs.
    Rezende CA; San Gil RAS; Borré LB; Pires JR; Vaiss VS; Resende JALC; Leitão AA; De Alencastro RB; Leal KZ
    J Pharm Sci; 2016 Sep; 105(9):2648-2655. PubMed ID: 26372719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution and Solid State Nuclear Magnetic Resonance Spectroscopic Characterization of Efavirenz.
    Sousa EGR; Carvalho EM; San Gil RADS; Santos TCD; Borré LB; Santos-Filho OA; Ellena J
    J Pharm Sci; 2016 Sep; 105(9):2656-2664. PubMed ID: 26886313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of a valinomycin-hexaaquamagnesium trifluoromethanesulfonate compound.
    Fujita M; Kazerouni AM; Bacsa J
    Acta Crystallogr C Struct Chem; 2016 Aug; 72(Pt 8):627-33. PubMed ID: 27487337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal and molecular structure of the depsipeptide ionophore hexadecaisoleucinomycin, cyclo-[(D-Ile-L-Lac-L-Ile-D-Hyi)4-] (C80H136N8O24).
    Pletnev VZ; Ivanov VT; Langs DA; Strong P; Duax WL
    Biopolymers; 1992 Jul; 32(7):819-27. PubMed ID: 1391633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR crystallography of campho[2,3-c]pyrazole (Z' = 6): combining high-resolution 1H-13C solid-state MAS NMR spectroscopy and GIPAW chemical-shift calculations.
    Webber AL; Emsley L; Claramunt RM; Brown SP
    J Phys Chem A; 2010 Sep; 114(38):10435-42. PubMed ID: 20815383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the 13C CP/MAS spectra of leucine.
    Belton PS; Gil AM; Tanner SF
    Solid State Nucl Magn Reson; 1992 Jun; 1(2):67-71. PubMed ID: 1365718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (13)C CP MAS NMR and crystal structure of methyl glycopyranosides.
    Paradowska K; Gubica T; Temeriusz A; Cyrański MK; Wawer I
    Carbohydr Res; 2008 Sep; 343(13):2299-307. PubMed ID: 18547551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of [D-Hyi2,L-Hyi4]meso-valinomycin revealed by X-ray analysis.
    Pletnev VZ; Mikhailova IYu ; Ivanova VT; Langs DA; Grochulski P; Duax WL
    Biopolymers; 1991 Mar; 31(4):409-15. PubMed ID: 1863692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valinomycin-proton interaction in low-polarity media.
    Kríz J; Dybal J; Makrlík E
    Biopolymers; 2006 Aug; 82(5):536-48. PubMed ID: 16538664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.